FENC
Fennec Pharmaceuticals Inc
10.40$
+0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -121.5% | – | – | – | – | – | -499.3% | – | -97.9% | – | |
| – | +236.1% | +207.0% | -93.4% | -6.1% | +163.0% | -67.8% | -35.9% | +104.0% | -98.0% | +2,499.9% | -3.8% | – | |
| – | -0.9% | +39.0% | -22.3% | +96.9% | -38.3% | -29.0% | +87.2% | +48.5% | +13.7% | -60.7% | +79.2% | – | |
| – | – | – | – | – | – | -700.3% | – | – | -227.1% | – | -382.7% | – | |
| – | – | – | – | +0.0% | -100.0% | – | – | – | – | – | -100.0% | – | |
| – | – | – | – | – | -200.0% | – | – | – | – | – | – | – | |
| – | +21.4% | +11.8% | +373.7% | +486.7% | -98.3% | – | – | – | – | – | – | – | |
| – | +2,750.7% | -119.8% | – | -305.4% | +2,212.9% | – | -179.1% | – | +1,089.4% | -95.1% | +0.8% | – | |
| – | – | +4,258.0% | -121.4% | – | – | – | – | – | +357.8% | -77.2% | -68.4% | – | |
| – | – | – | -121.5% | – | – | – | – | – | -499.3% | – | -97.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.